Sugi Predict

Sugi Predict / Compounds / SCHEMBL4469147

SCHEMBL4469147

SCHEMBL4469147

COc1ccc(C(=O)c2sc(Nc3ccc(C(=O)NC4CCOC4=O)cc3)c(C#N)c2N)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ MAPT P10636 7/20 0.43
▸ MELK Q14680 3/20 0.42
▸ POLB P06746 3/20 0.42
▸ GAA P10253 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ SCN9A Q15858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4468120 0.94 MAPT (0.45) ALDH1A1MEN1KMT2AHPGDALOX12
SCHEMBL4477182 0.86 MAPT (0.51) ALDH1A1MEN1KMT2AHPGDALOX12
SCHEMBL4488929 0.86 MELK (0.44) ALDH1A1MAPTMELKPOLBGAA
SCHEMBL4468052 0.82 MAPT (0.48) ALDH1A1MEN1KMT2AHPGDALOX12
SCHEMBL631695 0.82 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AHPGDALOX12
SCHEMBL4472094 0.80 MAPT (0.51) ALDH1A1MEN1KMT2AHPGDALOX12
SCHEMBL4476805 0.80 MAPT (0.46) ALDH1A1MEN1KMT2AHPGDALOX12
SCHEMBL4474220 0.80 MAPT (0.46) ALDH1A1MEN1KMT2AHPGDALOX12
SCHEMBL4478969 0.80 MELK (0.46) ALDH1A1MAPTMELKPOLBGAA
SCHEMBL4471831 0.79 MAPT (0.48) ALDH1A1MEN1KMT2AHPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-20060041006-A1 PDE4B inhibitors and uses therefor PLEXXIKON, INC. 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PDE4B, PDE7B, PDE4A ALDH1A1 802/4885MEN1 2737/4885KMT2A 2234/4885
US-20060041006-A1 PDE4B inhibitors and uses therefor PDE4B, PDE7B, PDE4A ALDH1A1 802/4885MEN1 2737/4885KMT2A 2234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.